Metabolism - Clinical and Experimental
Volume 47, Issue 12 , Pages 1477-1480, December 1998

Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: A study with aminoguanidine in C57/BLKsJ diabetic mice

Department of Vascular Biology and Safety Assessment, SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK

Received 5 January 1998; accepted 18 June 1998.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0026-0495(98)90073-7

Metabolism - Clinical and Experimental
Volume 47, Issue 12 , Pages 1477-1480, December 1998

Article Tools